Keene & Associates’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-74,623
| Closed | -$1.08M | – | 83 |
|
|
2023
Q4 | $1.08M | Sell |
74,623
-50,164
| -40% | -$723K | 0.89% | 32 |
|
|
2023
Q3 | $2.17M | Buy |
124,787
+9,258
| +8% | +$161K | 1.74% | 30 |
|
|
2023
Q2 | $2.4M | Buy |
115,529
+3,030
| +3% | +$63.1K | 1.87% | 30 |
|
|
2023
Q1 | $2.65M | Buy |
112,499
+53,467
| +91% | +$1.26M | 2.05% | 30 |
|
|
2022
Q4 | $1.65M | Sell |
59,032
-37,277
| -39% | -$1.04M | 1.47% | 27 |
|
|
2022
Q3 | $2.25M | Buy |
96,309
+2,511
| +3% | +$58.8K | 2.07% | 27 |
|
|
2022
Q2 | $3.17M | Buy |
93,798
+7,339
| +8% | +$248K | 2.96% | 13 |
|
|
2022
Q1 | $3.02M | Sell |
86,459
-2,380
| -3% | -$83.1K | 2.46% | 26 |
|
|
2021
Q4 | $2.71M | Buy |
+88,839
| New | +$2.71M | 2.34% | 27 |
|